3 Recruiting Bladder Cancer Clinical Trials in Arizona
Explore active bladder cancer research studies enrolling across Arizona. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Bladder Cancer Studies in Arizona
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
📍 Arizona Urology Specialists — Tucson, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
📍 Mayo Clinic in Arizona - Phoenix ( Site 0043) — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)
📍 Mayo Clinic — Scottsdale, Arizona
View Study & Checklist ➔